Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-058989
Filing Date
2025-06-12
Accepted
2025-06-12 17:53:40
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2517800-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2517800-2_4seq1.xml 4 4010
  Complete submission text file 0001104659-25-058989.txt   5624
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ, BLD. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address
Beck Joanne T. (Reporting) CIK: 0001768045 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 251044079